110 related articles for article (PubMed ID: 6686455)
1. Hemodynamic activity of different doses of sulmazole by infusion.
Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
[TBL] [Abstract][Full Text] [Related]
2. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
Hauf GF; Bubenheimer P; Roskamm H
Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
[TBL] [Abstract][Full Text] [Related]
3. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
Wollschläger H; Drexler H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
[TBL] [Abstract][Full Text] [Related]
4. [Sulmazole: a new positive inotropic agent].
Renard M; Jacobs P; Melot C; Dresse A; Bernard R
Ann Cardiol Angeiol (Paris); 1984; 33(4):219-22. PubMed ID: 6465815
[TBL] [Abstract][Full Text] [Related]
5. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
Nebel W; Sabin G; Surawitzki G
Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
Weikl A; Kohlschütter S; Durst OE; Lang E
Arzneimittelforschung; 1981; 31(1a):244-7. PubMed ID: 7195232
[TBL] [Abstract][Full Text] [Related]
7. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
Stauch M; Nechwatal W
Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
[TBL] [Abstract][Full Text] [Related]
8. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
[TBL] [Abstract][Full Text] [Related]
9. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
Thormann J; Kramer W; Schlepper M
Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
[TBL] [Abstract][Full Text] [Related]
10. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration.
el Allaf D; D'Orio V; Cremers S; Carlier J
G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393
[TBL] [Abstract][Full Text] [Related]
11. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
Drexler H; Wollschläger H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
von Meel JC
Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
[TBL] [Abstract][Full Text] [Related]
13. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
[TBL] [Abstract][Full Text] [Related]
14. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
[TBL] [Abstract][Full Text] [Related]
15. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
16. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
[TBL] [Abstract][Full Text] [Related]
17. [Effect of sulmazol on left ventricular function in congestive cardiomyopathy].
Maurer E; Klein W; Brandt D
Arzneimittelforschung; 1983; 33(5):760-3. PubMed ID: 6683555
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
19. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
[TBL] [Abstract][Full Text] [Related]
20. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
Benedikter L; Mey T
Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]